Abstract
Recipharm, a Swedish pharmaceutical services firm, has acquired Arranta Bio, a contract development and manufacturing organization (CDMO) specializing in microbiome therapeutics and messenger RNA production. It also bought Vibalogics, a virotherapy CDMO with expertise in making oncolytic viruses, viral vaccines, and gene therapies. Both firms are based in Massachusetts. Meanwhile, Recipharm plans to expand its sterile fill-and-finish capabilities at its facility in Monts, France, by adding a high-speed filling line.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
